Suberoylanilide Hydroxamic Acid Reactivates HIV from Latently Infected Cells

This publication has 56 references indexed in Scilit:

• Histone Hyperacetylation Occurs on Promoters of Lytic Cycle Regulatory Genes in Epstein-Barr Virus-Infected Cell Lines Which Are Refractory to Disruption of Latency by Histone Deacetylase Inhibitors
  Journal of Virology, 2008
• PP2B and PP1α cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca²⁺signaling
  Genes & Development, 2008
• Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle
  Proceedings of the National Academy of Sciences, 2008
• HDAC inhibitor reduces cytokine storm and facilitates induction of chimerism that reverses lupus in anti-CD3 conditioning regimen
  Proceedings of the National Academy of Sciences, 2008
• LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated
  Nucleic Acids Research, 2008
• Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription
  Nucleic Acids Research, 2007
• Modulation of a P-TEFb Functional Equilibrium for the Global Control of Cell Growth and Differentiation
  Molecular and Cellular Biology, 2006
• Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
  Blood, 2006
• Hexamethylbisacetamide Remodels the Human Immunodeficiency Virus Type 1 (HIV-1) Promoter and Induces Tat-Independent HIV-1 Expression but Blunts Cell Activation
  Journal of Virology, 2006
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
  Nature Reviews Cancer, 2006